Shuttle Pharmaceuticals Holdings Income Statement (2021-2026) | SHPH

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 0.19M0.44M0.30M0.08M0.67M-0.00M0.92M0.84M1.05M0.69M0.59M0.60M1.40M0.99M1.57M1.03M0.94M0.55M0.27M
Selling, General & Administrative (Quarter) 0.01M0.02M0.01M0.01M0.08M0.37M0.26M0.21M0.27M0.32M0.32M0.31M0.33M0.43M0.60M2.35M0.89M1.84M1.16M
Other Operating Expenses (Quarter) 0.05M0.53M0.33M0.26M0.33M0.16M0.37M0.42M0.29M0.27M0.47M0.57M1.32M0.36M0.78M0.54M0.44M1.10M0.79M
Operating Expenses (Quarter) 0.24M0.99M0.64M0.35M0.82M0.53M1.54M1.47M1.60M1.28M1.38M1.48M3.05M1.78M2.95M3.91M2.27M3.50M2.22M
Operating Income (Quarter) -0.24M0.60M-0.64M-0.35M-0.82M-0.53M-1.54M-1.47M-1.60M-1.28M-1.38M-1.48M-3.05M-1.78M-2.95M-3.91M-2.27M-2.79M-2.22M
EBIT (Quarter) -0.24M0.60M-0.64M-0.35M-0.82M-0.53M-1.54M-1.47M-1.60M-1.28M-1.38M-1.48M-3.05M-1.78M-2.95M-3.91M-2.27M-2.79M-2.22M
Non-operating items
Non Operating Investment Income (Quarter) 0.04M-0.03M0.01M0.05M-706.00-0.03M-0.04M
Interest & Investment Income (Quarter) 0.02M0.02M0.02M0.02M0.02M0.01M0.00M3.0081.00486.00523.00209.00
Other Non Operating Income (Quarter) 0.06M0.04M-0.06M0.11M-0.28M1.24M0.43M0.44M0.10M0.20M-0.14M0.29M0.22M0.00M0.01M0.00M-0.09M0.08M
Non Operating Income (Quarter) 0.03M0.53M-0.04M-0.24M-0.18M-2.19M0.57M-0.72M-0.19M-0.36M-0.35M-0.55M-0.73M0.18M-0.10M0.20M-0.08M0.17M0.06M
Net income details
EBT (Quarter) -0.22M-0.46M-0.68M-0.52M-1.00M-2.72M-0.98M-2.18M-1.78M-1.64M-1.86M-1.90M-3.05M-0.59M-2.96M-3.91M-2.27M-2.75M-2.23M
Profit After Tax (Quarter) -0.22M-0.46M-0.68M-0.60M-1.00M-0.75M-0.98M-2.18M-1.79M-1.64M-1.73M-2.03M-3.78M-1.60M-3.05M-3.71M-2.35M-2.59M-2.15M
Income from Continuing Operations (Quarter) -0.22M-0.46M-0.68M-0.52M-1.00M-2.72M-0.98M-2.18M-1.78M-1.64M-1.86M-1.90M-3.05M-0.59M-2.96M-3.91M-2.27M-2.75M-2.23M
Consolidated Net Income (Quarter) -0.22M-0.46M-0.68M-0.52M-1.00M-2.72M-0.98M-2.18M-1.78M-1.64M-1.86M-1.90M-3.05M-0.59M-2.96M-3.91M-2.27M-2.75M-2.23M
Income towards Parent Company (Quarter) -0.22M-0.46M-0.68M-0.52M-1.00M-2.72M-0.98M-2.18M-1.78M-1.64M-1.86M-1.90M-3.05M-0.59M-2.96M-3.91M-2.27M-2.75M-2.23M
Preferred Dividend Payments (Quarter) 0.03M0.03M0.03M0.03M0.02M0.33M
Net Income towards Common Stockholders (Quarter) -0.24M-0.48M-0.71M-0.62M-1.02M-4.40M-0.98M-2.18M-1.79M-1.64M-1.86M-1.90M-3.05M-0.59M-2.96M-3.91M-2.27M-2.75M-2.23M
Additional items
EPS (Basic) (Quarter) -0.02-0.05-0.07-0.06-0.10-4.81-0.57-1.23-0.91-0.81-0.83-24.12-39.836.65-7.60-3.29-1.050.06-0.43
EPS (Weighted Average and Diluted) (Quarter) -0.06-0.10-4.81-0.57-1.23-0.91-0.81-0.83-24.12-39.833.70-7.60-3.29-1.050.06-0.43
Shares Outstanding (Weighted Average) (Quarter) 9.30M0.01M9.31M9.29M9.72M1.34M1.70M1.74M1.97M1.87M2.08M0.08M0.09M0.11M0.40M0.77M1.26M1.64M5.03M
Shares Outstanding (Diluted Average) (Quarter) 9.29M1.34M1.70M1.74M1.97M1.87M2.08M0.08M0.09M0.12M0.40M1.13M1.26M1.64M5.03M
EBITDA (Quarter) -0.24M0.60M-0.64M-0.35M-0.82M-0.53M-1.54M-1.47M-1.60M-1.28M-1.38M-1.48M-3.05M-1.78M-2.95M-3.91M-2.27M-2.79M-2.22M
Interest Expenses (Quarter) 113.000.05M0.15M0.17M0.01M-0.00M0.60M0.73M0.62M0.53M0.50M0.43M0.00M-1.19M0.01M0.00M721.00-0.04M0.01M